RxDoctor Payments Data

Jacqueline Arant

Family · Chicago, ILNPI 1518470509

Payments from drug & device makers

$1,340in general payments, 2019–2025

Across 55 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$386
  • AbbVie$250
  • Lundbeck LLC$178
  • Johnson & Johnson$142
  • Otsuka America Pharmaceutical, Inc.$133
  • Vanda Pharmaceuticals Inc.$86
  • plus $166 from 3 others

What the payments were for

  • Food & beverage$1,340100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,340 in reported general payments places this provider in the 75th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$45,373
Medicare patients
11
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Escitalopram Oxalate12$24

Paid to pharmacies, not to this prescriber.

Other family in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →